Compounds > 2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide
Page last updated: 2024-09-03

2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide and Asthma

2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide has been researched along with Asthma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, M; Ishikawa, J; Masaki, K; Saitoh, C1

Other Studies

1 other study(ies) available for 2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide and Asthma

ArticleYear
Effect of YM934, a novel potassium-channel opener, in various experimental asthma models in guinea-pigs.
    The Journal of pharmacy and pharmacology, 1996, Volume: 48, Issue:10

    Topics: Administration, Oral; Animals; Anti-Asthmatic Agents; Asthma; Benzoxazines; Blood Pressure; Cyclic N-Oxides; Guinea Pigs; Heart Rate; Injections, Intravenous; Male; Oxazines; Potassium Channels

1996